Relatively more p62 expression and lower ratio of LC3-I/LC3-II were observed in treatment with AD-related cytokines IL-31 and IL-33, compared to IL-31 and IL-33 plus rapa treatments, suggesting that IL-31 and IL-33 could likely block autophagy. Here, MAP1LC3A is linked to Alzheimer disease.